Advanced Medical Optics (AMO) has completed its acquisition of IntraLase Corp.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Interdisciplinary report illuminates demographic, systemic health factors of dry eye disease
Remaining questions about DED pertain to geographic considerations, prevalence measures for DED in children and the design of future studies to determine risk factors in patients under 40
Higher Molar Dose and Its Translation into Clinical Practice
How a newly defined category of IOLs can benefit patient outcomes
A new functional classification can help achieve precise vision goals
European Commission grants label extension for Eylea 8 mg with extended 6-month treatment interval
Iridex enrolls first patient in study evaluating MicroPulse technology as an adjunct to anti-VEGF therapy for DME
The study will be led by principal investigator professor Noemi Lois, MD, PhD, FRCS(Ed), FRCOphth, at Queen’s University Belfast, in over 20 clinical sites, and plans to enroll 264 patients across the UK with severe DME.
Custom matching IOLs is key to managing patient satisfaction
Johann Krüger, MD, shares insights from 26 years of experience